6Indexed trials
drug · Product Intelligence
Cannabidiol
Pipeline Intelligence
Cannabidiol: 6 indexed trials, 6 sponsors; 33 linked Orange Book patents and 4 FDA-linked events where matched.
6Sponsors
33Orange Book patent links
4FDA-linked events
Development evidence
NCT02286986University of Utah · epilepsyPHASE1
NCT02815540Gillette Children's Specialty Healthcare · epilepsyPHASE1, PHASE2
NCT03467113Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. · epilepsyPHASE1
NCT03582137University of Colorado, Denver · parkinsonsPHASE2
NCT04504877University of Sao Paulo · ptsdPHASE2, PHASE3
NCT05015439Johns Hopkins University · autismPHASE1
FDA / patent evidence
12661365EPIDIOLEX · app 2103652042-09-24
11160795EPIDIOLEX · app 2103652041-03-01
11406623EPIDIOLEX · app 2103652041-03-01
12102619EPIDIOLEX · app 2103652041-03-01
11865102EPIDIOLEX · app 2103652039-04-26
11207292EPIDIOLEX · app 2103652039-04-26
10918608EPIDIOLEX · app 2103652035-10-13
11096905EPIDIOLEX · app 2103652035-10-13
11065209EPIDIOLEX · app 2103652035-10-13
11400055EPIDIOLEX · app 2103652035-10-13
11311498EPIDIOLEX · app 2103652035-06-17
11357741EPIDIOLEX · app 2103652035-06-17
Regulatory context
FDA_EXCLUSIVITYEPIDIOLEX · ODE-3262027-07-31
FDA_EXCLUSIVITYEPIDIOLEX · ODE-3322027-07-31
FDA_EXCLUSIVITYEPIDIOLEX · M-2702026-10-20
FDA_APPROVALEPIDIOLEX · 2018-09-28
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.